Jean-Michel Chezal Selected Research

N- (2- (diethylamino)ethyl)- 4- iodobenzamide

11/2011	New aldehyde and vinylsulfone proteasome inhibitors for targeted melanoma therapy.
6/2008	Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Michel Chezal Research Topics

Disease

31	Neoplasms (Cancer) 06/2022 - 06/2008
28	Melanoma (Melanoma, Malignant) 04/2022 - 06/2008
11	Chondrosarcoma 06/2022 - 09/2009
5	Hypoxia (Hypoxemia) 01/2021 - 01/2017
3	Diarrhea 05/2016 - 10/2007
2	Extraskeletal Myxoid Chondrosarcoma 01/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2015 - 10/2014
1	Cholangiocarcinoma 06/2022
1	Glioma (Gliomas) 06/2022
1	Tics (Tic) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Circulating Neoplastic Cells 11/2019
1	Peritoneal Neoplasms 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 03/2017
1	Hepatitis C 05/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2016
1	Inflammation (Inflammations) 05/2015
1	Arthritis (Polyarthritis) 05/2015
1	Pain (Aches) 05/2015
1	Rheumatoid Arthritis 05/2015

Drug/Important Bio-Agent (IBA)

19	Melanins (Melanin)IBA 04/2022 - 08/2008
16	Radioisotopes (Radionuclides)IBA 04/2022 - 06/2008
12	N- (2- diethylaminoethyl)- 6- iodoquinoxaline- 2- carboxamideIBA 04/2022 - 11/2008
10	Proteoglycans (Proteoglycan)IBA 01/2020 - 09/2009
8	ProdrugsIBA 01/2021 - 05/2011
8	LigandsIBA 01/2021 - 11/2011
6	Pharmaceutical PreparationsIBA 10/2017 - 05/2015
5	Ammonium CompoundsIBA 01/2020 - 11/2014
4	Idoxuridine (Stoxil)FDA LinkGeneric 09/2016 - 10/2013
3	pyridineIBA 01/2022 - 05/2010
3	Biological ProductsIBA 09/2016 - 08/2008
3	Iodine-125IBA 09/2016 - 05/2013
3	Peptides (Polypeptides)IBA 02/2015 - 11/2011
3	AcridinesIBA 08/2014 - 08/2008
2	benzamideIBA 04/2022 - 11/2011
2	ICF05016IBA 01/2021 - 01/2020
2	azomycinIBA 01/2020 - 11/2017
2	Aggrecans (Aggrecan)IBA 01/2020 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 03/2017
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2017 - 11/2014
2	IodineIBA 03/2016 - 11/2013
2	QuinoxalinesIBA 05/2014 - 08/2009
2	N- (2- (diethylamino)ethyl)- 4- iodobenzamideIBA 11/2011 - 06/2008
1	SolutionsIBA 06/2022
1	EnzymesIBA 06/2022
1	isocitric acid (isocitrate)IBA 06/2022
1	Oxidoreductases (Dehydrogenase)IBA 06/2022
1	Organotin CompoundsIBA 01/2022
1	copper(I) triflateIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	hydroxide ionIBA 01/2022
1	AntigensIBA 01/2021
1	fluoromisonidazoleIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2020
1	imidazoleIBA 01/2020
1	procaine isothiocyanate (PRIT)IBA 01/2019
1	Alkylating AgentsIBA 11/2017
1	phosphoramidic acidIBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	Chlorambucil (Leukeran)FDA Link 10/2017
1	Doxycycline (Periostat)FDA LinkGeneric 09/2017
1	Matrix Metalloproteinase InhibitorsIBA 09/2017
1	TetraspaninsIBA 03/2017
1	PolymersIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	GlycosaminoglycansIBA 01/2017
1	pimonidazoleIBA 01/2017
1	TH 302IBA 01/2017
1	TritiumIBA 11/2016
1	Subgenomic RNAIBA 05/2016
1	aniline (aniline hydrobromide)IBA 05/2016
1	3- (imidazo(1,2- a- 5,4- b')dipyridin- 2- yl)anilineIBA 05/2016
1	Cyclic NucleotidesIBA 04/2016
1	A-Form DNA (A-DNA)IBA 03/2016
1	DisulfidesIBA 08/2015
1	Glutathione (Reduced Glutathione)IBA 08/2015
1	Freund's AdjuvantIBA 05/2015
1	Meloxicam (Mobic)FDA LinkGeneric 05/2015
1	Dendrimers (Dendrons)IBA 03/2015
1	F 4 (F-4)IBA 03/2015
1	4-Nle-7-Phe-alpha- MSHIBA 02/2015
1	IntegrinsIBA 02/2015
1	N,N-diethylethylenediamineIBA 02/2015
1	Iodine-123IBA 01/2015
1	Siloxanes (Siloxane)IBA 11/2014

Therapy/Procedure

25	Therapeutics 04/2022 - 06/2008
7	Drug Therapy (Chemotherapy) 01/2020 - 08/2008
4	Radiotherapy 01/2021 - 06/2008
3	Radioimmunotherapy 10/2020 - 03/2017
2	Precision Medicine 10/2020 - 01/2017
2	Intravenous Injections 03/2015 - 04/2013
1	Neoadjuvant Therapy 01/2020
1	Immunotherapy 03/2017